Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000673948 | SCV000799209 | likely pathogenic | Usher syndrome type 2A; Retinitis pigmentosa 39 | 2018-04-06 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV003465533 | SCV004206313 | likely pathogenic | Retinitis pigmentosa 39 | 2023-02-27 | criteria provided, single submitter | clinical testing | |
Institute of Human Genetics, |
RCV004817907 | SCV005069835 | pathogenic | Retinal dystrophy | 2019-01-01 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV005240448 | SCV005886542 | pathogenic | Usher syndrome | 2025-02-13 | criteria provided, single submitter | clinical testing | Variant summary: USH2A c.8391delA (p.Gly2799ValfsX31) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. The variant allele was found at a frequency of 4e-06 in 251322 control chromosomes (gnomAD). To our knowledge, no occurrence of c.8391delA in individuals affected with Usher Syndrome and no experimental evidence demonstrating its impact on protein function have been reported. ClinVar contains an entry for this variant (Variation ID: 557769). Based on the evidence outlined above, the variant was classified as pathogenic. |